PeptiDream Inc
Save
2.20B
Market cap
15.45x
Current P/E
41.32x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases.
Similar securities
Based on sector and market capitalization
Report issue